"research and development expenses decreased by 8.5% to A$12.65 million"
Yet general expenses (wages, photocopier haha) huge increase
I would have thought R&D (bread and butter and core function of a clinical stage bio) would have increased with the five IP products, four of them at clinical trials ??
- Forums
- ASX - By Stock
- IMU
- Analysts Reports (Imugene)
Analysts Reports (Imugene), page-302
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.002(2.83%) |
Mkt cap ! $383.0M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.1¢ | $854.9K | 16.43M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
63 | 5765446 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 2256872 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 5649286 | 0.051 |
87 | 5528984 | 0.050 |
20 | 3242364 | 0.049 |
17 | 1314838 | 0.048 |
5 | 237373 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 2623293 | 23 |
0.053 | 1096311 | 14 |
0.054 | 1729278 | 5 |
0.055 | 1976897 | 14 |
0.056 | 890463 | 10 |
Last trade - 14.07pm 12/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |